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Background: From 2002 to 2005, interstage mortality was 7% after the modified Norwood operation in our program. We hypothesized that 
interstage home monitoring would identify infants at increased risk of decompensation and reduce interstage mortality.
Methods: In 2005, we implemented an interstage home monitoring program (HMP) for Norwood patients. Interstage was defined as the time 
between Norwood hospital discharge and admission for Glenn. All infants who survived to hospital discharge were enrolled, irrespective of location 
of outpatient followup. In the HMP, the family documented oxygen saturation, heart rate, weight, and feedings daily. Each family received extensive 
teaching about warning signs and changes in trends of monitored parameters. After discharge, nurse practitioners called each family at least weekly. 
Families were encouraged to call the HMP team at any time with concerns. When issues arose, depending on severity, patients were either called 
more frequently, seen by their cardiologist, or admitted.
Results: Since October 2005, 38 Norwood patients have survived to hospital discharge. Thirty seven had a modified Norwood with a right ventricle 
to pulmonary artery conduit, whereas 1 underwent modified Blalock Taussig shunt Norwood. All were enrolled in the HMP. Of these 38, 35 have 
completed stage two palliation; 3 await Glenn. Interstage survival was 100%. Sixteen patients (42%) were admitted in the interstage period; three 
were admitted twice. Fifteen (39%) required interstage interventions. Five (13%) required major interventions: conduit stenting, aortic arch balloon 
angioplasty, emergent shunt, and early Glenn. Ten (26%) had minor interventions: blood transfusion, intravenous hydration, diuresis, initiation of tube 
feedings, and therapy for arrhythmias.
Conclusion: Since initiation of an interstage HMP in October 2005, all infants discharged after the Norwood operation have survived the interstage 
period. The HMP altered clinical management in 40% of these patients. Home monitoring of oxygen saturation, heart rate, weight, and feedings, 
along with comprehensive care coordination, allowed timely interventions and reduced interstage mortality from 7% to 0%.
 
